RecruitingPhase 4NCT06507202

Comparison of Remimazolam and Propofol for Recovery of Ambulatory Upper Airway Surgery

Comparison of Remimazolam Versus Propofol-based General Anesthesia on Postoperative Quality of Recovery in Patients Undergoing Ambulatory Upper Airway Surgery: a Randomized Controlled Trial

Sponsor

Chung-Ang University Gwangmyeong Hospital

Enrollment

116 participants

Start Date

Jan 22, 2024

Study Type

INTERVENTIONAL

Conditions

Laryngeal Disease Nasal Disease Oral Cavity Disease Pharyngeal Diseases

Summary

The purpose of this study is to compare the effects of remimazolam and propofol on postoperative recovery time, complications, and safety in patients undergoing ambulatory upper airway surgery under general anesthesia.

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Propofol and a drug called Remimazolam for people with laryngeal disease, nasal disease, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 19 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.